Shoolini University scientist’s cancer research published in top International Journal

Solan, June 27,
In a proud moment for Shoolini University and the Indian scientific community, Dr. Deepak Kumar, Professor at the School of Pharmaceutical Sciences, has achieved a remarkable milestone by publishing his research in the world-renowned journal Nature Signal Transduction and Targeted Therapy. This prestigious journal, known for its high global reputation, now carries an impressive Impact Factor of 52.7.
Dr. Kumar’s groundbreaking study focuses on the mTOR signaling pathway, a vital biological system that controls key processes in our body. His research explains how mTOR influences the growth and spread of cancer, along with its role in aging, immunity, and metabolic health. The study has already gained significant attention worldwide, with more than 466 citations, showcasing its importance in the medical research community.
Speaking about his research, Dr. Kumar said, “Our aim was to better understand how the mTOR pathway works and how it can be targeted to treat cancer and other chronic diseases. The study shows that by controlling mTOR activity, we may be able to not only slow down cancer but also fight age-related diseases like neurological disorders and diabetes.”
The research highlights the dual role of the mTORC1 complex in improving immunity and possibly extending lifespan. These findings open new doors for developing therapies that can help fight cancer, boost immune health, and delay aging.
Prof. P.K. Khosla, Chancellor Shoolini University, said, “Dr. Kumar’s work has made us proud. His research puts Shoolini University at the forefront of cutting-edge medical science and shows our commitment to solving real-world health problems.”